Glaucoma prevalence appears higher than prior research has estimated, with approximately 4.22 million US adults affected.

The Prescription Drug User Fee Act date refers to the deadline set by the FDA for reviewing a NDA or Biologics License Application.

Early treatment of the first MOGAD acute attack may prevent future relapses and reduce long-term humoral autoimmunity in patients.

More than one-third of patients admitted to the hospital for surgery have adverse events, with more than half potentially preventable.

The Valeda ® Light Delivery System (LumiThera, Inc.) is the first ever FDA-authorized treatment for vision loss in dry AMD, the manufacturer reported. The technology was evaluated in the LIGHTSITE III ...

For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a lower risk for venous thromboembolism (VTE).

The number of Americans sickened in an E. coli outbreak tied to slivered onions used on McDonald's Quarter Pounders has now risen to 104.

ADHD and vision disorders have some key associations in both disease development and in terms of side effects of medications.

There was an increase in dyslipidemia incidence during the COVID-19 pandemic compared with the prepandemic period.

Sugar restriction during the first 1,000 days after conception lowers a child's risk for later developing type 2 diabetes and hypertension.

Myopic shift after lensectomy with IOL implantation is greater when children receive the surgery at a younger age.

Dexamethasone implants improve visual and anatomical outcomes better than brolucizumab in patients with both DME and hyperreflective intraretinal dots.